PillsCard
Almost ready…
PillsCard
Almost ready…
Ove informacije su namenjene isključivo u edukativne svrhe. Ne predstavljaju medicinski savet. Uvek se konsultujte sa kvalifikovanim zdravstvenim stručnjakom.
Opis, Doziranje, Neželjena dejstva, Kontraindikacije. Data from EMA, URPL, openFDA and other regulatory sources.
| Salbutamol | Salmeterol | |
|---|---|---|
| Aktivne supstance | Salbutamolum | Salmeterolum + Fluticasoni propionas |
| ATC šifra | R03AC02 | R03AK06 |
| Oblik | Aerozol inhalacyjny, zawiesina | Proszek do inhalacji, podzielony |
| Doziranje | 100 mcg/dawkę inh. | (50 mikrogramów + 250 mikrogramów)/dawkę |
| Način primene | wziewna | wziewna |
| Proizvođač | Exeltis Poland Sp. z o.o. | InPharm Sp. z o.o. |
Salbutamol (INN: Salbutamolum, ATC R03AC02) and Salmeterol (INN: Salmeterolum + Fluticasoni propionas, ATC R03AK06) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
Ove informacije su namenjene isključivo u edukativne svrhe. Ne predstavljaju medicinski savet. Uvek se konsultujte sa kvalifikovanim zdravstvenim stručnjakom.